| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Chief Scientific Officer
1 company
Dirk G. Brockstedt is Chief Scientific Officer at RAPT. From January 2020 to March 2026, the filings on record show 0 open-market purchases and 22 sales. Dirk G. Brockstedt's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Historically, Dirk G. Brockstedt's trades have earned a strong insider score of 71/100 across 16 rated trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +24.0%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2020 | RAPT Rapt Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 9,877 | $23.93 | $236,327.51 | -49.1% | |
| May 15, 2020 | RAPT Rapt Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 9,877 | $15.00 | $148,155.00 | -49.1% |